- AnPac Bio-Medical Science press release ( NASDAQ: ANPC ): 1H Adj. net loss of $6.6M.
- Revenue of $0.78M (-44.3% Y/Y).
For further details see:
AnPac Bio-Medical Science Adj. net loss of $6.6M, revenue of $0.78MFor further details see:
AnPac Bio-Medical Science Adj. net loss of $6.6M, revenue of $0.78MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
AnPac Bio-Medical Science Co. Ltd. Company Name:
ANPC Stock Symbol:
NASDAQ Market:
Fresh2 Group (NASDAQ: ANPC) , formerly AnPac Bio-Medical Science Co., a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on th...
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES' PR Newswire Ticker symbol change effective at the market open May 22, 2023 NEW YORK , May 19, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science...
Fresh2 Group Limited (NASDAQ: ANPC) , formerly AnPac Bio-Medical Science Co., a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform foc...